HeartFlow’s current products are HeartFlow Plaque analysis, which aims to provide clinicians with the ability to more ...

HeartFlow’s AI-based CAD platform targets a large market with strong adoption, but IPO valuation and risks warrant caution.

The Bain Capital-backed company's debut comes as expectations of a softer trade policy and lower interest rates boost ...

Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the closing of its upsized initial public offering of 19,166,667 shares of its ...

Heartflow announced today that it closed its upsized initial public offering (IPO) with proceeds totaling approximately $364.2 million.

Heartflow, a company involved in AI technology for coronary artery disease, went public on Friday under the ticker symbol HTFL, raising $316.7 million with its initial public offering. Late last week, ...

So far this year, just 16 funded U.S. startups in the biotech, drug discovery and medical device spaces have made their ...

We use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized content and targeted ads, to analyze our website traffic, and to understand ...

Kimball Electronics reported quarterly earnings of 34 cents per share which beat the analyst consensus estimate of 15 cents ...

This year's cohort of new issues are rallying on their first day of trading, which bodes well for IPOs to come.

Lightbridge Corporation ('Lightbridge” or the 'Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, and ...